Drug Trial Radar · NCT04527484
A Bioequivalence Study to Compare Two Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subjects
Last checked: Nov 19, 2026Latest source record: Aug 26, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
130
Planned (sponsor's estimate)
Start
Aug 20, 2020
Primary completion
Jan 10, 2021
Study completion Mar 30, 2021
Sponsor
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Aug 26, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will be a single-center, randomized, parallel, open-label, single dosing bridging study in healthy subjects to evaluate bioequivalence of two formulations of SHR-1314. Subjects will be randomly assigned to the Vials group, the PFS group at a ratio of 1:1
Conditions
- Bioequivalence
Interventions
SHR-1314Drug
each group subjects will be given different formulations of SHR-1314
Primary outcomes
What the sponsor says the trial is designed to measure.
- AUC0-last: Area under the serum concentration-time curve from time zero to the last measurable concentrationTime frame: from Day1 to Day113
- Cmax: Observed maximum serum concentrationTime frame: from Day1 to Day113
- AUC0-∞: Area under the serum concentration-time curve from time zero to infinityTime frame: from Day1 to Day113
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.